Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.
about
The emerging roles of exosomes in leukemogeneisMechanisms of Nuclear Export in Cancer and Resistance to ChemotherapyEffective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression levelAcalabrutinib (ACP-196): a selective second-generation BTK inhibitorSecond-generation inhibitors of Bruton tyrosine kinaseEfficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysisCombination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transitionIntegrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivityEmerging techniques in the isolation and characterization of extracellular vesicles and their roles in cancer diagnostics and prognostics.Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cellsSRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.Disruption of Wnt/β-catenin exerts anti-leukemia activity and synergizes with FLT3 inhibition in FLT3-mutant acute myeloid leukemia.Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.Clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system.Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelinationNotch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
P2860
Q26748606-3F21C9BA-3C43-40AE-8259-41E4E54659F4Q26764837-CB9353F6-7155-4F6B-8ED9-E5E758C0B4C7Q27300701-575F8156-EFD3-4593-82BD-DB274819FAD5Q28066316-C91C605E-0451-49EB-A694-CD1BDE47E48DQ28076118-32623126-6FD4-4283-843B-909B51474315Q28079362-25C163D8-BC02-416C-97D7-134045F7670DQ36642752-E89184B9-43CC-4E51-AF59-79D569D858B1Q37094051-021591D5-DEC4-4A9B-8ABF-BFDD2EF978F7Q37440060-E132A6AE-08EE-4D3D-B5E0-DFB9F5E33EE6Q37457890-09BD0542-74E7-454D-A4E8-9DA9DA2DBEA9Q38624837-2F83F93F-4BB3-4AE5-AEF6-BA61EFACD951Q42654709-0684C4D3-17B8-4936-AE9B-B2A96A37A438Q47221572-44428C8C-693E-420E-87FE-C447F97A22B5Q47783708-B858FF0E-3DC3-49E5-B359-9B9A516258F7Q49791849-1FDF25AD-9FA7-420D-B1F7-7C98D61324F7Q51122167-6CDADA04-F3DD-430D-B506-9D775F0D5647Q52577596-F37137C2-0CAC-4FE3-9D00-3B6DCD17B076Q53763092-D6A219C4-502D-49D0-B79E-F5D7842CDD2DQ54697325-29AC070B-1C4D-444D-976E-4B7C33CC6A11Q57157917-9FEDAC80-5529-491E-AC8B-30A2A8BD4C1FQ58705625-1C65D40E-283D-4B46-916D-38EE45B136A2
P2860
Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Galectin-3 mediates bone marro ...... t/β-catenin signaling pathway.
@ast
Galectin-3 mediates bone marro ...... t/β-catenin signaling pathway.
@en
type
label
Galectin-3 mediates bone marro ...... t/β-catenin signaling pathway.
@ast
Galectin-3 mediates bone marro ...... t/β-catenin signaling pathway.
@en
prefLabel
Galectin-3 mediates bone marro ...... t/β-catenin signaling pathway.
@ast
Galectin-3 mediates bone marro ...... t/β-catenin signaling pathway.
@en
P2093
P2860
P1476
Galectin-3 mediates bone marro ...... t/β-catenin signaling pathway.
@en
P2093
Binsheng Wang
Lizhen Liu
Xiaohong Yu
Yongxian Hu
P2860
P2888
P356
10.1186/S13045-014-0099-8
P50
P577
2015-01-27T00:00:00Z
P5875
P6179
1037839171